BioSpace News Archive

Business

Cytokinetics Reports Second Quarter 2021 Financial Results

Cytokinetics, Incorporated reported financial results for the second quarter of 2021. Net loss for the second quarter was $61.6 million, or $0.86 per share, compared to net loss for the second quarter of 2020 of $40.8 million, or $0.68 per share.

August 5, 2021
·
15 min read
Business

Addex Reports 2021 Half Year and Second Quarter Financial Results and Provides Corporate Update

Addex Therapeutics, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, reported its half-year and second quarter financial results for the periods ended June 30, 2021 and provided a corporate update.

August 5, 2021
·
8 min read
Vifor Pharma reports strong H1 2021 growth, on track to meet full year guidance1

Vifor Pharma Group reported profitable revenue growth in H1 supported by a strong recovery in Ferinject® / Injectafer® with sales up 22.8% at CER as a result of improved patient access as COVID-19 restrictions eased in key markets.

August 5, 2021
·
13 min read
Deals

Versant Ventures Announces Acquisition of Portfolio Company Vividion Therapeutics

Versant Ventures announced that portfolio company Vividion Therapeutics has been acquired by Bayer AG for $1.5 billion up front and up to $500 million in potential future milestone payments.

August 5, 2021
·
2 min read
Phototherapy Equipment Market: Growing Uptake of CFL to Boost Market Growth

The global phototherapy equipment market is highly competitive in nature and is expected to witness an increased level of competition throughout the forecast period, states a new research report by Transparency Market Research.

August 5, 2021
·
4 min read
Malaysia Medical Tourism Market is Expected to Attain Value of US$3.5 Bn by the End of 2024 with a CAGR of 30.05%

Transparency Market Research observes, the Malaysia medical tourism market is highly competitive due to presence of number of companies operating in the market.

August 5, 2021
·
4 min read
Business

Active Biotech AB Interim report January – June 2021

Active Biotech and NeoTX announce FDA clearance of IND for phase II clinical trial of naptumomab

August 5, 2021
·
1 min read
Business

Verona Pharma Reports Second Quarter 2021 Financial Results and Provides Corporate Update

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces its financial results for the three months ended June 30, 2021, and provides a corporate update.

August 5, 2021
·
15 min read
Business

Zealand Pharma Hosts Conference Call on August 12 at 4 pm CET (10am ET) to Present Second Quarter Results for 2021

Zealand Pharma A/S a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, announced that it will host a conference call on August 12, 2021 at 4 pm CET following the announcement of results for the second quarter of 2021.

August 5, 2021
·
3 min read
Biotech Beach

Praxis Bioresearch Awarded $2.9 Million Fast-Track SBIR Grant for Development of Novel Therapy for Apathy in Alzheimer’s Disease

Praxis is proud to announce to be the recipient of a Fast-Track SBIR award to develop treatment for apathy in Alzheimer’s Disease.

August 5, 2021
·
5 min read